The Pearson Lab
Weill Cornell Medicine · Center for Neurogenetics

Neural Stem Cells
& Brain Development

We aim to elucidate the intrinsic and extrinsic mechanisms that regulate neural stem cell fate. By determining how these regulatory mechanisms shape brain development, we hope to understand the basis of neurodevelopmental disorders such as epilepsy and Autism.

Neural Progenitor Biology Glucose Metabolism GLUT1 FOXP1 Cerebral Organoids
Research

Ongoing Projects

01

Glucose Metabolism & GLUT1 in Neural Development

Neural stem cells rely on glucose as their primary energy source, and GLUT1 is a key transporter controlling how these cells take up and use glucose to meet their metabolic demands. This project investigates how glucose metabolism within neural stem cells themselves shapes their behavior — including proliferation, differentiation, and long-term maintenance — and how disruptions in this intrinsic metabolic signaling contribute to abnormal brain development.

About GLUT1 Deficiency →
02

Modeling GLUT1 Deficiency Syndrome with Human Cerebral Organoids

GLUT1 Deficiency Syndrome is caused by mutations that impair glucose uptake and use, leading to seizures, developmental delay, and movement disorders. This project uses patient-derived human cerebral organoids to recreate the disease in a dish, allowing the lab to study how impaired glucose metabolism disrupts neural stem cell biology and to identify points where intervention might help.

About GLUT1 Deficiency →
03

FOXP1 Regulatory Pathways in Neural Stem Cells & Excitatory Neurons

FOXP1 is a transcription factor essential for normal brain development, and its mutation is linked to a spectrum of neurodevelopmental disorders. This project examines how FOXP1 regulates neural stem cell self-renewal and the specification of excitatory neurons, with a focus on how FOXP1 intersects with stress adaptation and metabolic signaling to coordinate the timing of neurogenesis.

About FOXP1 Syndrome →
04

Drug Repurposing Project to Identify Potential Treatments for GLUT1 Deficiency Syndrome

This project screens existing FDA-approved and investigational compounds for their ability to restore GLUT1 protein function. By repurposing known drugs rather than developing new ones from scratch, the goal is to accelerate the path to a viable treatment for patients and families affected by this rare disease.

About GLUT1 Deficiency →
Publications

Selected Work

2026
Tsao K, Bakis I, Sun S, Nakayama M, Kalmanson Z, Abd Elmagid L, Shuster JS, Xia Y, Eichenbaum JV, Yu FZ, McCain ML, Evans T, Pearson CA, Butcher JT, Cao J, et al., Harrison MRM
PNAS
2026
Al-Naama N, Pearson CA
Frontiers in Cellular Neuroscience
2025
Al Naama N, Konrad C, Sherif S, Raynaud C, Wang C, Lakhani S, Manfredi G, Pearson CA, Ross ME
bioRxiv (preprint)
2024
Buth JE, Dyevich CE, Rubin A, Wang C, Gao L, Marks T, Harrison MR, Kong JH, Ross ME, Novitch BG, Pearson CA
EMBO Reports
2022
Watanabe M, Buth JE, Haney JR, Vishlaghi N, Turcios F, Elahi LS, Gu W, Pearson CA, et al.
Stem Cell Reports
2020
Moore DM, Tucker HO, Dekker JD, Hu H, Miquelajáuregui A, Novitch BG, Pearson CA
Cell Reports
Full publication list on PubMed →
Google Scholar profile →
People

The Team

Caroline Alayne Pearson, PhD
Caroline Alayne Pearson, PhD
Principal Investigator · Assistant Professor
Center for Neurogenetics
Feil Family Brain and Mind Research Institute
Weill Cornell Medicine
[email protected]
Lab Members
NA
Njoud Al-Naama, PhD
Post Doctoral Researcher
NY
Nicole Yatskar
Technician
IF
Isabella Fogelman
Volunteer (Website Designer)
Alumni
CD
Catherine Dyevich
Technician · Pursuing Medical School
Alumni
AR
Alexandra Rubin
Volunteer · Pursuing Medical School
Alumni
AI
Annette Izumi
Technician · MIT Business School
Alumni

Interested in joining the Pearson Lab? We welcome motivated researchers at all career stages.

We welcome rotation students from the Weill Cornell and Tri-I graduate programs.

Send your CV to [email protected]
News

Lab Updates

July 2026
Caroline joins the early career editorial board at Stem Cell Reports.
June 2026
Technician Annette Izumi leaves the lab to start business school at MIT.
February 2026
Njoud and Caroline’s review on radial glial development and angiogenesis is published.
January 2026
The Pearson lab joins the GLUT1 Deficiency Foundation Collaborative Research Network.
January 2026
GLUT1 Deficiency Foundation grant awarded to start a drug repurposing project.
December 2025
Caroline joins the GLUT1 Deficiency Foundation Scientific Advisory Board.
March 28, 2025
The Pearson Lab’s first R01 grant has been approved for funding by NINDS.
December 1, 2024
The lab receives an R03 from NIH NIMH to continue FOXP1 studies in neural progenitor cells and neurons.
July 31, 2025
Farewell to Catherine Dyevich, who leaves to pursue her medical career.
October 31, 2024
Pearson lab celebrates exciting funding news.
Acknowledgments

Funding & Support

NIH / NINDS
NIH / NIMH
American Epilepsy Society
Brain & Spine Research Institute at NYP/WCM
Mastercard Diversity Mentorship Collaborative at WCM
Community

Patient & Family Resources

Contact

Get In Touch

Address

Belfer Research Building
413 East 69th Street
New York, NY 10065

Email

[email protected]

Institution

Center for Neurogenetics
Feil Family Brain and Mind Research Institute
Weill Cornell Medicine

Campus

The Pearson Lab is located in the Belfer Research Building on the Weill Cornell Medical College campus on the Upper East Side — steps from Memorial Sloan Kettering and Rockefeller University.